Skip to main content
LABU logo
LABU
(NYSEARCA)
Direxion Daily S&P Biotech Bull 3X ETF
$303.55-- (--)
Loading... - Market loading

LABU ETF: Direxion Daily S&P Biotech Bull 3X ETF - Price, Holdings & Analysis

Direxion Daily S&P Biotech Bull 3X ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$281.50 - $300.34
52-Week High$341.93
52-Week Low$68.00
Open$290.97
Volume258.36K
Average Volume (3M)389.14K
Assets (AUM)543.30M
Expense Ratio0.96%
Total Holdings169
Inception DateMay 28, 2015
1 Day Change-10.71%
1 Month Change27.36%
6 Month Change71.26%
YTD Change87.78%
1 Year Change326.47%
52-Week Change320.71%
5 Year Change-77.24%
10 Year Change-62.06%
50-Day MA$276.20
200-Day MA$195.47
RSI51.71
Stochastic %K43.88
Stochastic %D72.77
Annual Dividend$1.12
Dividend Yield0.38%
Last Dividend Ex-DateApr 1, 2026
Dividend Growth YoY243.56%
Years Dividend Growth1

Frequently Asked Questions About Direxion Daily S&P Biotech Bull 3X ETF

What is the current price of LABU?

The latest LABU price is $296.31. The 52-week range is $68.00–$341.93. LABU has returned 320.7% over the past 52 weeks.

What is the expense ratio for LABU?

LABU's annual expense ratio is 0.96%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does LABU pay dividends?

Yes, LABU pays a 0.38% dividend yield. The last ex-dividend date was 2026-04-01. View full dividend history in the Dividends section.

What are the top holdings of LABU?

LABU's largest holdings are TG Therapeutics, Inc (1.3%), Travere Therapeutics Inc (1.2%), Alkermes plc (1.2%) (combined weight: 3.7%). The fund holds 169 total positions. View the complete portfolio breakdown in the Holdings section.

How does LABU compare to similar ETFs?

Compare LABU (0.96% expense ratio, $543M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.